Get Premium to unlock powerful stock data
NYSE:TEVA (Israel)  
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

$ 7.54 -0.175 (-2.27%) 03:30 PM EST
P/E:
At Loss
P/B:
0.89
Market Cap:
$ 8.51B
Enterprise V:
$ 29.84B
Volume:
7.42M
Avg Vol (2M):
10.67M
Also Trade In:
Volume:
7.42M
Market Cap $:
8.51B
PE Ratio:
At Loss
Avg Vol (2-Month):
10.67M
Enterprise Value $:
29.84B
PB Ratio:
0.89
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Based in Israel, Teva is one of the world's largest generic drug manufacturers, with over 3,500 products marketed in over 60 countries. While a majority of its revenue is attributed to prescription generic drugs, Teva develops and markets its own branded specialty and biopharmaceutical products, primarily in the U.S. and in Europe. The company's branded portfolio generates one fifth of total revenue and consists of patented therapies targeting central nervous system conditions (Austedo, Ajovy, Copaxone), oncology (Bendeka/Treanda), and respiratory conditions (ProAir, Qvar). While global competition has facilitated the commodification of small-molecule generic drugs, Teva's portfolio rationalization has resulted in less overall price erosion versus peers.
Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset 0.2
Debt-to-Equity 2.5
Debt-to-EBITDA 14.16
Interest Coverage 3.62
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.18
Distress
Grey
Safe
Beneish M-Score -2.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 44.49
9-Day RSI 43.35
14-Day RSI 43.11
6-1 Month Momentum % 12.05
12-1 Month Momentum % -5.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.07
Quick Ratio 0.73
Cash Ratio 0.19
Days Inventory 187.12
Days Sales Outstanding 102.71
Days Payable 73.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4

Financials (Next Earnings Date:2022-07-27)

TEVA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:TEVA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 15,557
EPS (TTM) ($) -0.55
Beta 0.69
Volatility % 29.14
14-Day RSI 43.11
14-Day ATR ($) 0.352097
20-Day SMA ($) 8.0305
12-1 Month Momentum % -5.39
52-Week Range ($) 7.23 - 10.5
Shares Outstanding (Mil) 1,110.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Teva Pharmaceutical Industries Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More